Mylan Laboratories, Inc.
31 federal employment cases from public court records (2000–2019)
22 with a published ruling · 9 open dockets
What public court records show
Public federal court records list Mylan Laboratories, Inc. as an employer in 31 employment matters between 2000 and 2019.
Of the 21 matters with a recorded outcome, the most common were: 6 ended in a ruling for the employer, 6 had a mixed result, 4 ended in a ruling for the worker, and 3 were sent back to a lower court.
Workers obtained a favorable ruling in about 19% of matters with a recorded outcome.
The most common claims on record were Breach Of Contract, Wrongful Termination, and Wage Theft.
Cases were filed across 4 states, most often in DC.
These figures summarize publicly available U.S. federal court records only. Most workplace disputes are resolved privately and never appear in litigation. A case outcome reflects many factors and is not a finding that any employer violated the law.
Does not imply wrongdoing — many cases are dismissed or resolved without findings of liability.
AI-extracted from court records; figures may be amounts at issue, not amounts paid. Not a finding of liability.
About this employer
Mylan Laboratories, Inc. appears in 21 federal employment-law court rulings on record. These cases sit within the healthcare sector, where employment disputes commonly involve HIPAA-adjacent retaliation, nursing-license issues, and accommodations under the ADA. The set below covers rulings that produced written federal-court decisions; private settlements, EEOC charges resolved without litigation, and state-court cases are not included.
The cases primarily involve Breach of Contract (4 of 21), Wrongful Termination (3 of 21), Wage Theft. Browse the linked claim hubs for outcome statistics and other employers facing the same allegations. Breach of Contract, Wrongful Termination and Wage Theft.
Rulings span District of Columbia (4), West Virginia (4), Massachusetts (3), Pennsylvania (1). District of Columbia is an EEOC deferral state, which extends the federal Title VII / ADA / ADEA filing deadline from 180 to 300 days. Browse state-specific employment rulings for jurisdictional patterns. District of Columbia rulings, West Virginia rulings, Massachusetts rulings and Pennsylvania rulings.
Case Outcomes
Case Stages
The stage at which courts issued Mylan Laboratories, Inc.’s 21 stage-identified rulings.
Of the 3 summary-judgment rulings, 0 ended the case in Mylan Laboratories, Inc.’s favor and 3 let the worker’s claims continue.
What do these stages mean?
- Appeal
- A higher court reviewing an earlier decision. Many published opinions come from this stage, after a lot has already happened in the case.
- Summary judgment
- A ruling where the judge decides the case — or part of it — without a trial, because one side argues the key facts are not in dispute. For workers, getting past this step is often the biggest hurdle.
- Motion to dismiss
- An early request — usually by the employer — to throw the case out before any evidence is gathered.
- Settlement / consent decree
- The two sides resolved the dispute by agreement, sometimes with court approval. Most settlements are private and never show up in published opinions.
- Other rulings
- Procedural decisions and orders that do not fit the main stages above.
Published federal-court opinions only — most workplace disputes are resolved privately. This is not anyone’s odds, and not a finding that any employer violated the law.
Facing something similar? Check your rights →
Claim Types
Federal cases
public court recordsOne row per case · a badge means the case reached a published ruling · plaintiff names redacted
Other Healthcare employers
Browse rulings involving similar workplaces.
Data sourced from public federal court records via CourtListener.com. Case outcomes extracted using AI analysis. This information is for educational purposes only and does not constitute legal advice. The presence of an employer on this page does not imply wrongdoing — many cases are dismissed or resolved without findings of liability.